Skip to main content

Table 1 Patient baseline characteristics.

From: Changes in anti-viral effectiveness of interferon after dose reduction in chronic hepatitis c patients: a case control study

Patient characteristics Group 1 (1) Group 2 (1)
Number of patients 9 15
Median age 44 47
Male/Female 7 / 2 11 / 4
Race (Caucasian / Asian) 7 / 2 15 / 0
Pre-treatment RNA HCV 5.5. × 106 7.5 × 106
Genotype 1 All All
Median ALT at baseline 89 122
Cirrhosis/No-cirrhosis 4 / 5 1 / 14
Previous NR / other * 6 / 3 11 / 4
  1. *) Non-sustained responder to previous therapy or previously untreated patients with cirrhosis and genotype 1.